Additionally, previous evidence has illustrated NF-κB activation and its role in driving breast cancer development and progression via its role in cancer stem cells (CSC), epithelial to mesenchymal transition (EMT) and resistance to endocrine and chemotherapies. Here, NFKB1 is linked to breast carcinoma.